Immediate Impact

28 standout
Sub-graph 1 of 13

Citing Papers

Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial
2025 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
2 intermediate papers

Works of Constanze Schneider being referenced

The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1
2018
Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance
2016

Author Peers

Author Last Decade Papers Cites
Constanze Schneider 88 64 28 19 165
Gentry Teng King 43 100 36 20 179
R Egido 120 72 35 22 267
Seongmin Choi 112 35 11 19 218
Bhuvana Srinivasan 54 78 15 15 170
Robert C. Squatrito 71 125 28 14 255
Marina Sánchez‐Frías 141 41 19 24 247
Allan Schuss 57 101 33 13 190
Guanhua Wu 150 58 30 17 221
Mohamed Fawzy 51 59 28 27 170
Florian Roßner 66 59 48 16 178

All Works

Loading papers...

Rankless by CCL
2026